Published in Drug Alcohol Depend on May 04, 2011
A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Aff (Millwood) (2013) 2.09
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat (2014) 1.08
Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study. Am J Epidemiol (2013) 1.05
Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend (2013) 1.03
"Bureaucracy & Beliefs": Assessing the Barriers to Accessing Opioid Substitution Therapy by People Who Inject Drugs in Ukraine. Drugs (Abingdon Engl) (2015) 0.90
Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend (2015) 0.87
The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment. J Subst Abuse Treat (2016) 0.85
The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study. Subst Abuse Treat Prev Policy (2014) 0.84
The relationship between recovery and health-related quality of life. J Subst Abuse Treat (2014) 0.81
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat (2015) 0.79
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities. Am Psychol (2013) 0.78
Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy. J Int AIDS Soc (2016) 0.77
Quality of Life in Methadone Maintenance Treated Patients in Iran. Int J High Risk Behav Addict (2015) 0.75
Quality of life as an outcome of opioid use disorder treatment: A systematic review. J Subst Abuse Treat (2017) 0.75
A Preliminary Study Examining Women's Physical Health and Nonmedical Prescription Opioid Use in a Recovering Framework. J Womens Health (Larchmt) (2017) 0.75
Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder. J Subst Abuse Treat (2016) 0.75
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Invest (2010) 5.77
Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med (2009) 5.60
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS (2003) 5.53
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ (2003) 4.38
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ (2002) 3.70
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis (2004) 3.20
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med (2009) 3.03
Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology (2002) 2.99
Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (2002) 2.74
Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ (2004) 2.63
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ (2004) 2.62
The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr (2003) 2.37
Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med (2002) 2.31
Leaving hospital against medical advice among HIV-positive patients. CMAJ (2002) 2.24
Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse (2006) 2.22
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Aff (Millwood) (2013) 2.09
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place (2004) 1.90
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J (2004) 1.77
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis (2003) 1.77
Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse (2005) 1.77
Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health (2005) 1.73
Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73
Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr (2002) 1.69
Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. Int J Epidemiol (2004) 1.67
Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health (2003) 1.66
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Staging for antiretroviral therapy among HIV-infected drug users. JAMA (2004) 1.64
Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys (2006) 1.64
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Sexual violence among a cohort of injection drug users. Soc Sci Med (2003) 1.61
Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study. Clin Trials (2009) 1.58
Effect of sociodemographic factors on surgical consultations and hip or knee replacements among patients with osteoarthritis in British Columbia, Canada. J Rheumatol (2010) 1.57
The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55
Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum (2004) 1.54
The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr (2003) 1.54
Workplace, psychosocial factors, and depressive symptoms among working people with arthritis: a longitudinal study. J Rheumatol (2006) 1.54
Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep (2005) 1.53
Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med (2010) 1.52
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend (2006) 1.51
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics (2005) 1.50
Reflecting on governance for CMAJ. CMAJ (2006) 1.49
Putting Communities in the Driver's Seat: The Realities of Community-Engaged Medical Education. Acad Med (2015) 1.46
Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ (2004) 1.44
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat (2010) 1.44
The effect of waiting time on pain intensity after elective surgical lumbar discectomy. Spine J (2013) 1.42
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ (2005) 1.42
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS (2002) 1.41
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci (2009) 1.41
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. CMAJ (2011) 1.40
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health (2003) 1.38
An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health (2003) 1.38
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37
The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr (2004) 1.36
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.33
The birth of the Canadian Academy of Health Sciences. Clin Invest Med (2005) 1.33
Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat (2006) 1.32
The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities. Soc Sci Med (2008) 1.29
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addict Behav (2005) 1.27
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr (2004) 1.27
Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000. BMC Health Serv Res (2005) 1.27
Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26